Mio Hamatani, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 253 | 0.610 |
Why?
|
Multiple Sclerosis | 3 | 2022 | 3213 | 0.580 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 259 | 0.540 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 820 | 0.530 |
Why?
|
Alanine-tRNA Ligase | 1 | 2016 | 7 | 0.530 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2016 | 43 | 0.510 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2016 | 104 | 0.500 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 550 | 0.500 |
Why?
|
Niemann-Pick Disease, Type C | 1 | 2016 | 57 | 0.500 |
Why?
|
Neuroglia | 1 | 2020 | 964 | 0.450 |
Why?
|
Axons | 1 | 2020 | 1682 | 0.390 |
Why?
|
Monocytes | 1 | 2020 | 2595 | 0.350 |
Why?
|
Heterozygote | 1 | 2016 | 2794 | 0.320 |
Why?
|
Autistic Disorder | 1 | 2016 | 1239 | 0.260 |
Why?
|
Sulfoglycosphingolipids | 1 | 2022 | 32 | 0.200 |
Why?
|
Disease Progression | 3 | 2022 | 13632 | 0.170 |
Why?
|
Syndrome | 2 | 2016 | 3271 | 0.170 |
Why?
|
Phenotype | 2 | 2023 | 16721 | 0.160 |
Why?
|
Myasthenia Gravis | 1 | 2021 | 214 | 0.150 |
Why?
|
Schizophrenia | 1 | 2016 | 6972 | 0.140 |
Why?
|
Filipin | 1 | 2016 | 14 | 0.130 |
Why?
|
B-Lymphocyte Subsets | 1 | 2017 | 241 | 0.130 |
Why?
|
Mutation | 2 | 2020 | 30198 | 0.120 |
Why?
|
Japan | 2 | 2016 | 1415 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1087 | 0.120 |
Why?
|
Toll-Like Receptor 4 | 1 | 2017 | 586 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15880 | 0.110 |
Why?
|
Flow Cytometry | 2 | 2020 | 5881 | 0.100 |
Why?
|
Interleukin-10 | 1 | 2017 | 1183 | 0.100 |
Why?
|
Staining and Labeling | 1 | 2016 | 1072 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1145 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4642 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4108 | 0.070 |
Why?
|
Genetic Loci | 1 | 2016 | 2631 | 0.070 |
Why?
|
Fibroblasts | 1 | 2016 | 4159 | 0.060 |
Why?
|
Alleles | 1 | 2016 | 6897 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10261 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4778 | 0.060 |
Why?
|
Genetic Testing | 1 | 2016 | 3595 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3000 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4752 | 0.050 |
Why?
|
Adult | 5 | 2021 | 223044 | 0.050 |
Why?
|
Humans | 9 | 2023 | 765968 | 0.040 |
Why?
|
Receptor Cross-Talk | 1 | 2017 | 118 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2023 | 1375 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2017 | 197 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10808 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2015 | 189 | 0.030 |
Why?
|
Mice | 1 | 2022 | 81819 | 0.030 |
Why?
|
Male | 5 | 2021 | 363698 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 81514 | 0.030 |
Why?
|
Female | 5 | 2021 | 396112 | 0.030 |
Why?
|
Stroke | 1 | 2015 | 9747 | 0.030 |
Why?
|
Heart Failure | 1 | 2015 | 11840 | 0.020 |
Why?
|
Animals | 1 | 2022 | 168764 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27171 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3432 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36532 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4015 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6499 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9649 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26318 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18973 | 0.010 |
Why?
|
Anticoagulants | 1 | 2015 | 4862 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39193 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21480 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5189 | 0.010 |
Why?
|
Aged | 2 | 2021 | 171117 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23601 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 223009 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40065 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59489 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74840 | 0.000 |
Why?
|